Mechanism of Action and Synergistic Effect of Eugenia Uniflora Extract in Candida Spp

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 Aug 13

PMID 39137202

Authors

Luanda B F C Souza

Aurelio de Oliveira Bento

Estela M G Lourenco

Magda R A Ferreira

Wogenes N Oliveira

Luiz Alberto L Soares

Euzebio G Barbosa

Hugo A O Rocha

Guilherme Maranhao Chaves

Affiliations

Soon will be listed here.

Abstract

The limited arsenal of antifungal drugs have prompted the search for novel molecules with biological activity. This study aimed to characterize the antifungal mechanism of action of Eugenia uniflora extract and its synergistic activity with commercially available antifungal drugs on the following Candida species: C. albicans, C. tropicalis, C. glabrata, C. parapsilosis and C. dubliniensis. In silico analysis was performed to predict antifungal activity of the major compounds present in the extract. Minimal inhibitory concentrations (MICs) were determined in the presence of exogenous ergosterol and sorbitol. Yeast cells were grown in the presence of stressors. The loss of membrane integrity was assessed using propidium iodide staining (fluorescence emission). Synergism between the extract and antifungal compounds (in addition to time kill-curves) was determined. Molecular docking revealed possible interactions between myricitrin and acid gallic and enzymes involved in ergosterol and cell wall biosynthesis. Candida cells grown in the presence of the extract with addition of exogenous ergosterol and sorbitol showed 2 to 8-fold increased MICs. Strains treated with the extract revealed greater loss of membrane integrity when compared to their Fluconazole counterparts, but this effect was less pronounced than the membrane damage caused by Amphotericin B. The extract also made the strains more susceptible to Congo red and Calcofluor white. A synergistic action of the extract with Fluconazole and Micafungin was observed. The E. uniflora extract may be a viable option for the treatment of Candida infections.

References

Sun F, Li M, Gu L, Wang M, Yang M . Recent progress on anti-Candida natural products. Chin J Nat Med. 2021; 19(8):561-579. DOI: 10.1016/S1875-5364(21)60057-2. View

Newman D, Cragg G . Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod. 2020; 83(3):770-803. DOI: 10.1021/acs.jnatprod.9b01285. View

Gil-Bona A, Marcela Parra-Giraldo C, Hernaez M, Reales-Calderon J, Solis N, Filler S . Candida albicans cell shaving uncovers new proteins involved in cell wall integrity, yeast to hypha transition, stress response and host-pathogen interaction. J Proteomics. 2015; 127(Pt B):340-351. PMC: 4721921. DOI: 10.1016/j.jprot.2015.06.006. View

Schwartz S, Kontoyiannis D, Harrison T, Ruhnke M . Advances in the diagnosis and treatment of fungal infections of the CNS. Lancet Neurol. 2018; 17(4):362-372. DOI: 10.1016/S1474-4422(18)30030-9. View

Cavalheiro M, Teixeira M . Biofilms: Threats, Challenges, and Promising Strategies. Front Med (Lausanne). 2018; 5:28. PMC: 5816785. DOI: 10.3389/fmed.2018.00028. View

Lee Y, Puumala E, Robbins N, Cowen L . Antifungal Drug Resistance: Molecular Mechanisms in and Beyond. Chem Rev. 2020; 121(6):3390-3411. PMC: 8519031. DOI: 10.1021/acs.chemrev.0c00199. View

Abdelfattah M, Ibrahim M, Abdullahi H, Aminu R, Saad S, Krstin S . Eugenia uniflora and Syzygium samarangense extracts exhibit anti-trypanosomal activity: Evidence from in-silico molecular modelling, in vitro, and in vivo studies. Biomed Pharmacother. 2021; 138:111508. DOI: 10.1016/j.biopha.2021.111508. View

Frost D, Brandt K, Cugier D, Goldman R . A whole-cell Candida albicans assay for the detection of inhibitors towards fungal cell wall synthesis and assembly. J Antibiot (Tokyo). 1995; 48(4):306-10. DOI: 10.7164/antibiotics.48.306. View

Bowman S, Free S . The structure and synthesis of the fungal cell wall. Bioessays. 2006; 28(8):799-808. DOI: 10.1002/bies.20441. View

10.

Silva D, Sardi J, Freires I, Cristina Barbosa Silva A, Rosalen P . In silico approaches for screening molecular targets in Candida albicans: A proteomic insight into drug discovery and development. Eur J Pharmacol. 2018; 842:64-69. DOI: 10.1016/j.ejphar.2018.10.016. View

11.

Lemos A, Campos L, Souza T, Paula P, Da Silva J, Coimbra E . Isolation and Chemical Characterization of Antifungal, Antioxidant, and Anti-Inflammatory Compounds from Centrosema coriaceum using GC/MS, UFLC-QTOF-MS, and FACE. Chem Biodivers. 2022; 20(1):e202200624. DOI: 10.1002/cbdv.202200624. View

12.

Teodoro G, Ellepola K, Seneviratne C, Koga-Ito C . Potential Use of Phenolic Acids as Anti-Candida Agents: A Review. Front Microbiol. 2016; 6:1420. PMC: 4685070. DOI: 10.3389/fmicb.2015.01420. View

13.

Lima S, Colombo A, de Almeida Junior J . Fungal Cell Wall: Emerging Antifungals and Drug Resistance. Front Microbiol. 2019; 10:2573. PMC: 6881460. DOI: 10.3389/fmicb.2019.02573. View

14.

Souza L, Silva-Rocha W, Ferreira M, Soares L, Svidzinski T, Milan E . Influence of Eugenia uniflora Extract on Adhesion to Human Buccal Epithelial Cells, Biofilm Formation, and Cell Surface Hydrophobicity of Candida spp. from the Oral Cavity of Kidney Transplant Recipients. Molecules. 2018; 23(10). PMC: 6222389. DOI: 10.3390/molecules23102418. View

15.

Stone N, Bicanic T, Salim R, Hope W . Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions. Drugs. 2016; 76(4):485-500. PMC: 4856207. DOI: 10.1007/s40265-016-0538-7. View

16.

Bongomin F, Gago S, Oladele R, Denning D . Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision. J Fungi (Basel). 2018; 3(4). PMC: 5753159. DOI: 10.3390/jof3040057. View

17.

Matta D, Souza A, Colombo A . Revisiting Species Distribution and Antifungal Susceptibility of Candida Bloodstream Isolates from Latin American Medical Centers. J Fungi (Basel). 2018; 3(2). PMC: 5715916. DOI: 10.3390/jof3020024. View

18.

Srivastava V, Singla R, Dubey A . Emerging Virulence, Drug Resistance and Future Anti-fungal Drugs for Candida Pathogens. Curr Top Med Chem. 2018; 18(9):759-778. DOI: 10.2174/1568026618666180528121707. View

19.

Salazar-Aranda R, Granados-Guzman G, Perez-Meseguer J, Gonzalez G, Waksman de Torres N . Activity of Polyphenolic Compounds against Candida glabrata. Molecules. 2015; 20(10):17903-12. PMC: 6332047. DOI: 10.3390/molecules201017903. View

20.

Baumgartner C, Freydiere A, Gille Y . Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates. J Clin Microbiol. 1996; 34(2):454-6. PMC: 228820. DOI: 10.1128/jcm.34.2.454-456.1996. View